Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 9
1964 12
1965 10
1966 19
1967 18
1968 16
1969 31
1970 24
1971 38
1972 34
1973 46
1974 48
1975 25
1976 42
1977 42
1978 43
1979 43
1980 46
1981 52
1982 64
1983 69
1984 89
1985 86
1986 87
1987 104
1988 114
1989 133
1990 191
1991 202
1992 170
1993 176
1994 278
1995 204
1996 228
1997 208
1998 221
1999 209
2000 227
2001 206
2002 234
2003 268
2004 322
2005 265
2006 286
2007 317
2008 289
2009 307
2010 314
2011 305
2012 364
2013 404
2014 367
2015 436
2016 427
2017 420
2018 366
2019 441
2020 525
2021 518
2022 473
2023 524
2024 190

Text availability

Article attribute

Article type

Publication date

Search Results

11,422 results

Results by year

Filters applied: . Clear all
Page 1
Interstitial lung diseases.
Wijsenbeek M, Suzuki A, Maher TM. Wijsenbeek M, et al. Lancet. 2022 Sep 3;400(10354):769-786. doi: 10.1016/S0140-6736(22)01052-2. Epub 2022 Aug 11. Lancet. 2022. PMID: 35964592 Review.
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised. Most interstitial lung diseases are characterised by inflammation or fibrosis within the interstitial space, the primary consequence of whic …
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised. Most interstitial
Hypersensitivity pneumonitis: new concepts and classifications.
Churg A. Churg A. Mod Pathol. 2022 Jan;35(Suppl 1):15-27. doi: 10.1038/s41379-021-00866-y. Epub 2021 Sep 16. Mod Pathol. 2022. PMID: 34531525 Free article. Review.
Fibrotic hypersensitivity pneumonitis may take the form of interstitial fibrosis confined to the peribronchiolar regions, or fibrotic nonspecific interstitial pneumonia, or a process similar to and sometimes indistinguishable from usual interstitial pn …
Fibrotic hypersensitivity pneumonitis may take the form of interstitial fibrosis confined to the peribronchiolar regions, or f …
Interstitial lung disease.
Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Antoniou KM, et al. Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Eur Respir Rev. 2014. PMID: 24591661 Free PMC article. Review.
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. ...Early diagnosis and disease stratification is also important in the field of other interstitial lung d
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidi
Immunomodulatory treatment of interstitial lung disease.
van den Bosch L, Luppi F, Ferrara G, Mura M. van den Bosch L, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221117002. doi: 10.1177/17534666221117002. Ther Adv Respir Dis. 2022. PMID: 35938712 Free PMC article. Review.
Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory treatment options compared with IPF, due to their inflammatory component. ...We then reviewed practical therapeutic approaches in connective tis
Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory trea
Smoking-Related Interstitial Lung Diseases.
Alarcon-Calderon A, Vassallo R, Yi ES, Ryu JH. Alarcon-Calderon A, et al. Immunol Allergy Clin North Am. 2023 May;43(2):273-287. doi: 10.1016/j.iac.2023.01.007. Epub 2023 Mar 1. Immunol Allergy Clin North Am. 2023. PMID: 37055089 Review.
Smoking-related interstitial lung diseases (ILDs) are a group of heterogeneous, diffuse pulmonary parenchymal disease processes associated with tobacco exposure. ...This review summarizes the current evidence of pathogenesis, clinical manifestations, diagnost …
Smoking-related interstitial lung diseases (ILDs) are a group of heterogeneous, diffuse pulmonary parenchymal disease p …
Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment.
Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Barnes H, et al. Allergy. 2022 Feb;77(2):442-453. doi: 10.1111/all.15017. Epub 2021 Jul 29. Allergy. 2022. PMID: 34293188 Review.
Hypersensitivity pneumonitis is an immune-mediated interstitial lung disease caused by an aberrant response to an inhaled exposure, which results in mostly T cell-mediated inflammation, granuloma formation, and fibrosis in some cases. ...Additional testing in …
Hypersensitivity pneumonitis is an immune-mediated interstitial lung disease caused by an aberrant response to an inhal …
Smoking-associated interstitial lung disease: update and review.
Dawod YT, Cook NE, Graham WB, Madhani-Lovely F, Thao C. Dawod YT, et al. Expert Rev Respir Med. 2020 Aug;14(8):825-834. doi: 10.1080/17476348.2020.1766971. Epub 2020 May 22. Expert Rev Respir Med. 2020. PMID: 32379511 Review.
AREAS COVERED: This review provides an overview of the epidemiology, risk factors, pathogenesis, clinical features, diagnosis, and treatment of acute eosinophilic pneumonia, e-cigarettes, or vaping associated lung injury, respiratory bronchiolitis interstitial lu
AREAS COVERED: This review provides an overview of the epidemiology, risk factors, pathogenesis, clinical features, diagnosis, and treatment …
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.
Swain SM, Nishino M, Lancaster LH, Li BT, Nicholson AG, Bartholmai BJ, Naidoo J, Schumacher-Wulf E, Shitara K, Tsurutani J, Conte P, Kato T, Andre F, Powell CA. Swain SM, et al. Cancer Treat Rev. 2022 May;106:102378. doi: 10.1016/j.ctrv.2022.102378. Epub 2022 Mar 12. Cancer Treat Rev. 2022. PMID: 35430509 Free article. Review.
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Interstitial lung disease (ILD)/pneumonitis is an adverse event associated with T-DXd; in most cases, it is low grade (grade 2) and can b …
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Interstitial
Interstitial Lung Disease: A Review.
Maher TM. Maher TM. JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669. JAMA. 2024. PMID: 38648021 Review.
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. ...In the …
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fi …
Diagnosis, course and management of hypersensitivity pneumonitis.
Hamblin M, Prosch H, Vašáková M. Hamblin M, et al. Eur Respir Rev. 2022 Feb 9;31(163):210169. doi: 10.1183/16000617.0169-2021. Print 2022 Mar 31. Eur Respir Rev. 2022. PMID: 35140104 Free PMC article. Review.
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease (ILD) that occurs when susceptible individuals develop an exaggerated immune response to an inhaled antigen. ...A proportion of patients with fibrotic HP develop a prog …
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease (ILD) that occurs when susce …
11,422 results
You have reached the last available page of results. Please see the User Guide for more information.